These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 28771725)
1. TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells. Sun NK; Huang SL; Chang TC; Chao CC J Cell Physiol; 2018 Mar; 233(3):2489-2501. PubMed ID: 28771725 [TBL] [Abstract][Full Text] [Related]
2. Role of the TLR4-androgen receptor axis and genistein in taxol-resistant ovarian cancer cells. Huang SL; Chang TC; Chao CCK; Sun NK Biochem Pharmacol; 2020 Jul; 177():113965. PubMed ID: 32278794 [TBL] [Abstract][Full Text] [Related]
3. Androgen receptor transcriptional activity and chromatin modifications on the ABCB1/MDR gene are critical for taxol resistance in ovarian cancer cells. Sun NK; Kohli A; Huang SL; Chang TC; Chao CC J Cell Physiol; 2019 Jun; 234(6):8760-8775. PubMed ID: 30317630 [TBL] [Abstract][Full Text] [Related]
4. TLR4/IL-6/IRF1 signaling regulates androgen receptor expression: A potential therapeutic target to overcome taxol resistance in ovarian cancer. Huang SL; Chang TC; Chao CCK; Sun NK Biochem Pharmacol; 2021 Apr; 186():114456. PubMed ID: 33556340 [TBL] [Abstract][Full Text] [Related]
5. Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor. Sun NK; Huang SL; Lu HP; Chang TC; Chao CC Oncotarget; 2015 Sep; 6(29):27065-82. PubMed ID: 26318424 [TBL] [Abstract][Full Text] [Related]
6. TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. Szajnik M; Szczepanski MJ; Czystowska M; Elishaev E; Mandapathil M; Nowak-Markwitz E; Spaczynski M; Whiteside TL Oncogene; 2009 Dec; 28(49):4353-63. PubMed ID: 19826413 [TBL] [Abstract][Full Text] [Related]
7. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells. Gaikwad SM; Thakur B; Sakpal A; Singh RK; Ray P Int J Biochem Cell Biol; 2015 Apr; 61():90-102. PubMed ID: 25681684 [TBL] [Abstract][Full Text] [Related]
8. Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway. Yang YI; Lee KT; Park HJ; Kim TJ; Choi YS; Shih IeM; Choi JH Carcinogenesis; 2012 Dec; 33(12):2488-98. PubMed ID: 23027625 [TBL] [Abstract][Full Text] [Related]
9. Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation. Cai G; Ma X; Chen B; Huang Y; Liu S; Yang H; Zou W Tumour Biol; 2016 Sep; 37(9):11883-11891. PubMed ID: 27059733 [TBL] [Abstract][Full Text] [Related]
10. UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis. Wang J; Ye C; Liu J; Hu Y Biochem Biophys Res Commun; 2018 Jul; 501(4):1034-1040. PubMed ID: 29777711 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of Tyro3 receptor tyrosine kinase leads to the acquisition of taxol resistance in ovarian cancer cells. Lee C Mol Med Rep; 2015 Jul; 12(1):1485-92. PubMed ID: 25815442 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs. Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496 [TBL] [Abstract][Full Text] [Related]
13. Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway. Huang JM; Zhang GN; Shi Y; Zha X; Zhu Y; Wang MM; Lin Q; Wang W; Lu HY; Ma SQ; Cheng J; Deng BF Sci Rep; 2014 Jan; 4():3840. PubMed ID: 24452475 [TBL] [Abstract][Full Text] [Related]
14. HOXB4 knockdown enhances the cytotoxic effect of paclitaxel and cisplatin by downregulating ABC transporters in ovarian cancer cells. Li Y; Sun J; Gao S; Hu H; Xie P Gene; 2018 Jul; 663():9-16. PubMed ID: 29660518 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line. Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763 [TBL] [Abstract][Full Text] [Related]
16. Cepharanthine hydrochloride reverses P‑glycoprotein-mediated multidrug resistance in human ovarian carcinoma A2780/Taxol cells by inhibiting the PI3K/Akt signaling pathway. Huang CZ; Wang YF; Zhang Y; Peng YM; Liu YX; Ma F; Jiang JH; Wang QD Oncol Rep; 2017 Oct; 38(4):2558-2564. PubMed ID: 28791369 [TBL] [Abstract][Full Text] [Related]
17. [The selection of taxol resistance associated genes in ovarian cancer cell line by mRNA DD]. Cheng G; Tian F; Li Y Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):541-3. PubMed ID: 11798816 [TBL] [Abstract][Full Text] [Related]
18. [Preliminary study of the prohibitin protein and paclitaxel resistance in ovarian cancer]. Tang J; Cao L; Yi H; Tang C Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1221-7. PubMed ID: 23281375 [TBL] [Abstract][Full Text] [Related]
19. CCL20 Promotes Ovarian Cancer Chemotherapy Resistance by Regulating ABCB1 Expression. Su S; Sun X; Zhang Q; Zhang Z; Chen J Cell Struct Funct; 2019; 44(1):21-28. PubMed ID: 30760665 [TBL] [Abstract][Full Text] [Related]
20. Synthetic paclitaxel-octreotide conjugate reverses the resistance of paclitaxel in A2780/Taxol ovarian cancer cell line. Shen Y; Zhang XY; Chen X; Fan LL; Ren ML; Wu YP; Chanda K; Jiang SW Oncol Rep; 2017 Jan; 37(1):219-226. PubMed ID: 27878277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]